Home › Funds › Carmignac Gestion › COR

Carmignac Gestion position in COR

CENCORA INC · Health Care

Carmignac Gestion reported holding 1,344,823 shares of COR (CENCORA INC) in its Q3 2026 13F filing — a position valued at US$403.8M, representing 6.42% of its reported portfolio and ranking #2 among its reported holdings. Carmignac Gestion has disclosed COR holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)1.34M sh
Reported value held$403.82M
Portfolio Weight6.42%
First reportedQ2 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Carmignac Gestion's COR position evolved

Carmignac Gestion first disclosed a stake in COR in Q2 2024 at 963,873 shares (US$217.2M). The position peaked in Q2 2026 at 1,747,363 shares, worth US$494.5M. Across 10 filings, Carmignac Gestion increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,344,823 shares valued at US$403.8M — a reduction of -402,540 shares quarter over quarter.. Notable position changes include a 26% increase in Q1 2026 (shares fell 10% over the following quarter), a 59% increase in Q2 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 963.87K $217.16M New
Q3 2024 1.02M $229.58M Add
Q4 2024 1.00M $225.02M Reduce
Q1 2025 1.10M $306.86M Add
Q2 2025 922.49K $276.61M Reduce
Q3 2025 875.85K $273.71M Reduce
Q4 2025 875.10K $295.57M Hold
Q1 2026 1.10M $345.93M Add
Q2 2026 1.75M $494.46M Add
Q3 2026 1.34M $403.82M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COR and 13F data

COR (CENCORA INC) is a Health Care company. 32 other funds we track also report a position in COR — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$2.10B), Boston Partners (US$1.58B), Mawer Investment Management Ltd. (US$413.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COR

All COR fund holders →

FAQ

How long has Carmignac Gestion held COR?

Carmignac Gestion has disclosed COR holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Carmignac Gestion's current position in COR?

As of Q3 2026, Carmignac Gestion holds 1.34M shares of COR (CENCORA INC), valued at $403.82M, representing 6.42% of its reported portfolio and ranking #2.

Has Carmignac Gestion been buying or selling COR?

In the latest 13F filing (Q3 2026), Carmignac Gestion reduced its position in COR. The position peaked in Q2 2026 at 1.75M shares.

Which other funds hold COR?

Other major institutional holders of COR include T. Rowe Price Investment Management, Inc., Boston Partners, Mawer Investment Management Ltd., among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.